Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells
about
Multifunctional fructans and raffinose family oligosaccharidesStudies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: validating its traditional usageAntibiofilm polysaccharidesGut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectivesOligosaccharide structure determines prebiotic role of β-galactomannan against Salmonella enterica ser. Typhimurium in vitroEffect of Saccharomyces cerevisiae var. Boulardii and β-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88)β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cellsReview on the effects of potential prebiotics on controlling intestinal enteropathogens Salmonella and Escherichia coli in pig production.Effects of a synbiotic on fecal quality, short-chain fatty acid concentrations, and the microbiome of healthy sled dogsGlycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans.Newer insights into the mechanism of action of Psidium guajava L. leaves in infectious diarrhoeaGut microbiota, probiotics and diabetes.A prebiotic, Celmanax™, decreases Escherichia coli O157:H7 colonization of bovine cells and feed-associated cytotoxicity in vitro.Identification and characterization of complex bioactive oligosaccharides in white and red wine by a combination of mass spectrometry and gas chromatography.Exopolysaccharides synthesized by Lactobacillus reuteri protect against enterotoxigenic Escherichia coli in piglets.Identification and accurate quantitation of biological oligosaccharide mixtures.Prebiotics to fight diseases: reality or fiction?Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal ProbiomeImpact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health.High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome.Inhibition of Adhesion of Enteropathogenic Escherichia coli to HEp-2 Cells by Binding of a Novel Peptide to EspB Protein.ILSI Brazil International Workshop on Functional Foods: a narrative review of the scientific evidence in the area of carbohydrates, microbiome, and healthIn Vitro Fermentation of caprine milk oligosaccharides by bifidobacteria isolated from breast-fed infantsThe interplay between fiber and the intestinal microbiome in the inflammatory response.Plant cell wall polysaccharides as potential resources for the development of novel prebioticsPrebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel.Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods.A Randomized Clinical Trial Evaluating the Effects of Oligosaccharides on Transfer of Passive Immunity in Neonatal Dairy CalvesGalactooligosaccharides: novel components of designer foods.Production, health aspects and potential food uses of dairy prebiotic galactooligosaccharides.Physiological properties of milk ingredients released by fermentation.Analysis, structural characterization, and bioactivity of oligosaccharides derived from lactose.Prebiotics: A Potential Treatment Strategy for the Chemotherapy-damaged Gut?Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin.The intestinal glycome and its modulation by diet and nutrition.Adherence Reduction of Campylobacter jejuni and Campylobacter coli Strains to HEp-2 Cells by Mannan Oligosaccharides and a High-Molecular-Weight Component of Cranberry Extract.Pasture flock chicken cecal microbiome responses to prebiotics and plum fiber feed amendments.Pathogen-induced secretory diarrhea and its prevention.Galacto-oligosaccharides may directly enhance intestinal barrier function through the modulation of goblet cells.Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis.
P2860
Q21129208-EF3075BA-053A-4BC6-9065-B19F97B99834Q21254643-78DB8D33-9EF1-4E9D-A8FE-485110D83159Q26830763-55CD3CF6-042E-464A-A344-15945F56093CQ26864127-E2BAEA84-C873-4A94-A8D8-E5679711DAC7Q28709458-FF49F455-08A8-4783-809A-CFFA3ACBF7BEQ28731280-7F8A86B8-837E-4C2D-B8FF-9A8437A0407AQ28731499-95BB0449-55F9-4794-B395-4696040D238FQ30239923-1FDAEE13-ACEA-4782-B61F-2D13C598B639Q31145888-520CAB16-D3F9-441A-BF34-794BA9DAC214Q33508402-317B4490-BD32-4AE4-817A-5DBE44B88B1EQ33618359-56ED1BE4-9F6B-41CC-AC7A-2E7B4BE5D448Q33831849-B3A8C290-F7AB-413A-A9DC-BFF8D8BBB496Q33865231-383B8A33-21D1-4955-B018-DE3DE9B677EAQ34201382-B7DB3BE1-F53E-4278-9529-B59E0663184AQ34260980-A5D6ED33-3CEA-404A-9F86-F7D3DF22A173Q34381583-570A939E-028F-47BE-AF19-0FBFE7DEB25FQ34529060-584E6470-D105-4DDC-95D0-8566C481A6B7Q34881370-1BED05DE-A439-47BA-9E40-9DE0A05EBD89Q35665369-E3E2DC1C-2F18-4988-A860-FC7BBCA38CE2Q35912744-92A977F2-6240-4364-A8A2-EB786E297C49Q36035612-FAD40DD6-B2B4-4834-A135-401A35664566Q36597604-9F4C05FE-7C8A-47CC-8F00-7C14646AB580Q36782192-D6ADE123-65A5-4FAB-8624-19CD207C5E3AQ36828774-75BEC604-776D-4B2E-89B9-DA28BCCA0B0EQ37145360-89747131-B107-482A-8E94-BD6A1E0C9239Q37151924-5C6FFFA4-ACF0-4977-8D9C-2E70BB001D80Q37268269-F7722B23-F457-47EF-9A60-51084BE25E22Q37384871-6D3A9C62-7195-4DDE-AB72-F4BC96F46041Q37993630-175D50E8-9C69-4FCB-B698-FFC1447225F7Q38005925-6D9665EA-D6AD-4A34-A65D-2FF95881BADCQ38056616-4F8F0CDA-1E69-4389-BF52-3A7B3398709AQ38180439-D43D5CDA-2911-4AB7-A80A-6DE10884171EQ38243820-FBB1C164-3589-4D2B-8894-A65572176FD2Q38306400-FE86DD18-2C22-4ACC-9432-0345FA66439FQ38503059-F3878BA8-A0DD-4C5D-91A9-9D1E94FB2AB0Q38848555-486B7F48-BEFA-461C-A373-4871EA7D6FE5Q38878707-674BD502-1F0E-4649-9B75-12F86645745FQ38912737-A278D177-58FF-4B04-A0CC-4CBCAF73FDA9Q38938168-396D9945-8FF7-42C1-B6AB-58488B9910AFQ38955406-FD7F45BA-A8F6-40E3-B20F-97D8046EDE9B
P2860
Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prebiotic galactooligosacchari ...... a coli to tissue culture cells
@ast
Prebiotic galactooligosacchari ...... a coli to tissue culture cells
@en
type
label
Prebiotic galactooligosacchari ...... a coli to tissue culture cells
@ast
Prebiotic galactooligosacchari ...... a coli to tissue culture cells
@en
prefLabel
Prebiotic galactooligosacchari ...... a coli to tissue culture cells
@ast
Prebiotic galactooligosacchari ...... a coli to tissue culture cells
@en
P2093
P2860
P356
P1476
Prebiotic galactooligosacchari ...... a coli to tissue culture cells
@en
P2093
George L Mulvey
Glen D Armstrong
Kari Shoaf
Robert W Hutkins
P2860
P304
P356
10.1128/IAI.01030-06
P407
P577
2006-09-18T00:00:00Z